Ascend Laboratories, LLC recalls Dabigatran Etexilate
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
- Products
-
- Dabigatran Etexilate
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 1971 bottles
- About this recall
- Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60